ID: Brigatinib
- Product Name: 1-methyl-4-(piperidin-4-yl)-piperazine
- CAS No.: 53617-36-0
- THERAPEUTIC CATEGORY: small-molecule targeted cancer therapy
Salinthix Therapeutics is dedicated to advancing global healthcare through innovative, high-quality pharmaceutical solutions.
Copyright © 2026 Salinthix Therapeutics | Designed by Apex Logic Solutions